Understanding the myelodysplastic syndromes

Oncologist

Volumn 2, Issue 6, 1997, Pages 389-401

  Kouides, Peter A ^a,b   Bennett, John M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b ROCHESTER GENERAL HOSPITAL   (United States)

Author keywords

Apoptosis; Bone marrow transplantation; Erythropoietin; International Prognostic Scoring System; Myelodysplastic syndrome; Topotecan

Indexed keywords

AMIFOSTINE; CYCLOSPORIN; CYTARABINE; CYTOKINE; DANAZOL; DEFEROXAMINE; ERYTHROPOIETIN; FERRITIN; FLUOXYMESTERONE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; MELPHALAN; TAMOXIFEN; THROMBOPOIETIN; THYMOCYTE ANTIBODY; TOPOTECAN;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW HYPOPLASIA; CAUSE OF DEATH; CLINICAL TRIAL; CYTOPENIA; ERYTHROCYTE TRANSFUSION; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ADMINISTRATION; MALIGNANT TRANSFORMATION; MYELODYSPLASIA; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; PRIORITY JOURNAL; PROGNOSIS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031444395     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.2-6-389     Document Type: Article

References (19)

1. Ho PJ, Gibson J, Vincent P et al. The myelodysplastic syndromes: diagnostic criteria and laboratory evaluation. Pathology 1993;25:297-304.
2. Galton DA. The myelodysplastic syndromes. Part I. What are they? Part II. Classification. Scand J Haematol 1986;45(suppl):11-20.
3. Kouides PA, Bennett JM. Myelodysplastic syndromes. In: Abeloff MD, Armitage JO, Lichter AS, et al., eds. Clinical Oncology. New York: Churchill Livingstone, 1995:1977-1998.
4. Schumacher HR, Nand S. Myelodysplastic Syndromes: Approach to Diagnosis and Treatment. New York: Igaku-Shoin, 1995.
5. Hofmann WK, Ottmann OG, Ganser A et al. Myelodysplastic syndromes: clinical features. Semin Hematol 1996;33:177-185.
6. Farhi DC. Myelodysplastic syndromes and acute myeloid leukemia. Diagnostic criteria and pitfalls. Pathology Annual 1995;30:29-57.
7. Kouides PA, Bennett JM. Morphology and classification of the myelodysplastic syndromes and their pathologic variants. Semin Hematol 1996;33:95-110.
8. Raza A, Gezer S, Mundle S et al. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 1995;86:268-276.
9. Raza A, Mundle S, Iftikhar A et al. Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. Am J Hematol 1995;48:143-154.
10. Raza A, Mundle S, Shetty V et al. A paradigm shift in myelodysplastic syndromes. Leukemia 1996;10:1648-1652.
11. Lepelley P, Campergue L, Grardel N et al. Is apoptosis a massive process in myelodysplastic syndromes? Br J Haematol 1996;95:368-371.
12. Magill MK, Macfarlane E, McMullin MR Intramedullary apoptosis may simply be a correlate of ineffective hematopoiesis. Br J Haematol 1997;97(suppl 1):17.
13. Yoshida Y, Anzai N, Kawabata H. Apoptosis in myelodysplasia: a paradox or paradigm. Leuk Res 1995;19:887-891.
14. Rajapaksa R, Ginzton N, Rott LS et al. Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells. Blood 1996;88:4275-4287.
15. Mundle SD, Venugopal P, Cartlidge JD et al. Indication of an involvement of interleukin-1 beta converting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromes. Blood 1996;88:2640-2647.
16. Raza A, Shetty V, Dar S et al. Successful anti-cytokine based approach to treat myelodysplastic syndromes. Leuk Res 1997;21(suppl 1):S40.
17. Nemunaitis J, Rosenfeld C, Getty L et al. Pentoxifylline and ciprofloxacin in patients with myelodysplastic syndrome. A phase II trial. Am J Clin Oncol 1995;18:189-193.
18. Hamblin T. Clinical features of MDS. Leuk Res 1992;16:89-93.
19. Joosten E, Pelemans W, Hiele M et al. Prevalence and causes of anaemia in a geriatric hospitalized population. Gerontology 1992;38:111-117.